Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.

Patsali P, Turchiano G, Papasavva P, Romito M, Loucari CC, Stephanou C, Christou S, Sitarou M, Mussolino C, Cornu TI, Antoniou MN, Lederer CW, Cathomen T, Kleanthous M.

Haematologica. 2019 Nov;104(11):e497-e501. doi: 10.3324/haematol.2018.215178. Epub 2019 Apr 19. No abstract available.

2.

Erratum to: Delivery of Designer Epigenome Modifiers into Primary Human T Cells.

Mlambo T, Romito M, Cornu TI, Mussolino C.

Methods Mol Biol. 2018;1767:E1. doi: 10.1007/978-1-4939-7774-1_26. No abstract available.

PMID:
29748848
3.

Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells.

Mlambo T, Nitsch S, Hildenbeutel M, Romito M, Müller M, Bossen C, Diederichs S, Cornu TI, Cathomen T, Mussolino C.

Nucleic Acids Res. 2018 May 18;46(9):4456-4468. doi: 10.1093/nar/gky171.

4.

Delivery of Designer Epigenome Modifiers into Primary Human T Cells.

Mlambo T, Romito M, Cornu TI, Mussolino C.

Methods Mol Biol. 2018;1767:189-203. doi: 10.1007/978-1-4939-7774-1_9. Erratum in: Methods Mol Biol. 2018;1767:E1.

PMID:
29524135
5.

Refining strategies to translate genome editing to the clinic.

Cornu TI, Mussolino C, Cathomen T.

Nat Med. 2017 Apr 3;23(4):415-423. doi: 10.1038/nm.4313. Review.

PMID:
28388605
6.

Editing CCR5: a novel approach to HIV gene therapy.

Cornu TI, Mussolino C, Bloom K, Cathomen T.

Adv Exp Med Biol. 2015;848:117-30. doi: 10.1007/978-1-4939-2432-5_6. Review.

PMID:
25757618
7.

Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.

Händel EM, Gellhaus K, Khan K, Bednarski C, Cornu TI, Müller-Lerch F, Kotin RM, Heilbronn R, Cathomen T.

Hum Gene Ther. 2012 Mar;23(3):321-9. doi: 10.1089/hum.2011.140. Epub 2011 Dec 14.

8.

Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion.

Söllü C, Pars K, Cornu TI, Thibodeau-Beganny S, Maeder ML, Joung JK, Heilbronn R, Cathomen T.

Nucleic Acids Res. 2010 Dec;38(22):8269-76. doi: 10.1093/nar/gkq720. Epub 2010 Aug 16.

9.

Quantification of zinc finger nuclease-associated toxicity.

Cornu TI, Cathomen T.

Methods Mol Biol. 2010;649:237-45. doi: 10.1007/978-1-60761-753-2_14.

PMID:
20680838
10.

Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells.

Gellhaus K, Cornu TI, Heilbronn R, Cathomen T.

Hum Gene Ther. 2010 May;21(5):543-53. doi: 10.1089/hum.2009.167.

PMID:
20021219
11.

Unexpected failure rates for modular assembly of engineered zinc fingers.

Ramirez CL, Foley JE, Wright DA, Müller-Lerch F, Rahman SH, Cornu TI, Winfrey RJ, Sander JD, Fu F, Townsend JA, Cathomen T, Voytas DF, Joung JK.

Nat Methods. 2008 May;5(5):374-5. doi: 10.1038/nmeth0508-374. No abstract available. Erratum in: Nat Methods. 2008 Jun;5(6):575.

PMID:
18446154
12.

DNA-binding Specificity Is a Major Determinant of the Activity and Toxicity of Zinc-finger Nucleases.

Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M, Joung JK, Cathomen T.

Mol Ther. 2008 Feb;16(2):352-358. doi: 10.1038/sj.mt.6300357. Epub 2016 Dec 7.

PMID:
28178540
13.

DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases.

Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M, Joung JK, Cathomen T.

Mol Ther. 2008 Feb;16(2):352-8. Epub 2007 Nov 20. Erratum in: Mol Ther. 2008 Nov;16(11):1898. Joung, J K [corrected to Joung, J Keith].

14.

Targeted genome modifications using integrase-deficient lentiviral vectors.

Cornu TI, Cathomen T.

Mol Ther. 2007 Dec;15(12):2107-13. Epub 2007 Nov 13.

15.

Cells expressing the RING finger Z protein are resistant to arenavirus infection.

Cornu TI, Feldmann H, de la Torre JC.

J Virol. 2004 Mar;78(6):2979-83.

17.

Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.

Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki H, Holz A, Thomas D, Billeter MA, Oldstone MB.

Virology. 2001 Dec 20;291(2):215-25.

19.

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice.

Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA, Fielding AK.

Blood. 2001 Jun 15;97(12):3746-54.

PMID:
11389012
20.

Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses.

Wang Z, Hangartner L, Cornu TI, Martin LR, Zuniga A, Billeter MA, Naim HY.

Vaccine. 2001 Mar 21;19(17-19):2329-36.

PMID:
11257357

Supplemental Content

Loading ...
Support Center